Skip to content

The (cost) effectiveness of increasing daily protein intake to 1.2 gram per kilo body weight on physical functioning in community-dwelling older adults with a habitual daily protein intake < 1.0 gram per kilo body weight

The (cost) effectiveness of increasing daily protein intake to 1.2 gram per kilo body weight on physical functioning in community-dwelling older adults with a habitual daily protein intake < 1.0 gram per kilo body weight - Effectiveness of protein intake on physical funtioning

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48815
Enrollment
132
Registered
2018-10-10
Start date
2018-12-04
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fysiek functioneren Physical functioning

Interventions

This RCT consists of three groups
two intervention groups and one control group. Intervention group 1 (N=44 at each study site) will receive personalized dietary advice aimed at increasing protein intake to 1.2 g/kg body weight/d w

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age * 65 years; - Community-dwelling; - Lower protein intake defined as both a probability score above a certain cutoff on the protein screener (www.proteinscreener.nl) as well as based on actual protein intake assessed by 24-hour recalls. The protein screener was developed and validated using an extended FFQ among Dutch older adults. The cutoff will be chosen based on results of different studies in which we compare the probability scores of the protein screener with protein intake as measured with food diaries and/or dietary recalls. We will then choose the probability score that is most closely associated with a protein intake

Exclusion criteria

Exclusion criteria: - Bedridden or wheelchair bound; - Individuals who do not go outside; - Individuals with bad hearing (who cannot hear without a hearing aid); - Diagnosed with diabetes mellitus type I; - Diagnosed with diabetes mellitus type 2 and starting with insulin; - Diagnosed with severe kidney disease; - Diagnosed with Parkinson*s disease; - Current treatment of cancer (with the exception of basal cell carcinoma); - BMI 32.0 kg/m2 (self-reported, and assessed at study baseline); - Vegan; - Allergies to certain food products (such as peanuts, gluten); - Alcohol abuse past 6 months (AUDIT-C * 2); - Diagnosed with an eating disorder (self-reported); - Current participation to supervised behavioral or lifestyle intervention that intervenes with PROMISS intervention; - Planning to move out of the study area in the next 6 months; - Actively trying to lose or gain weight; - Not able to complete the 400 meter walk test (self-reported, and assessed at study baseline).

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is change in walk time on the 400 meter walk test.

Secondary

MeasureTime frame
Secondary outcomes are change in dietary intake (including macro- and micronutrients), malnutrition prevalence, physical performance, mobility limitations, muscle strength, body weight and body composition, frailty status, quality of life, and health care costs.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)